Publications by authors named "Thomas Muster"

Claim this Profile
D
Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium.
Victor M Cnossen, Paula C Leao Moreira, Othmar G Engelhardt, Jerzy Samolej, Geert H Groeneveld, Thomas Muster

Front Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity.
Raveen Rathnasinghe, Lauren A Chang, Rebecca Pearl, Sonia Jangra, Amy Aspelund, Thomas Muster

NPJ Vaccines· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients.
Christoph Jindra, Edmund K Hainisch, Andrea Rümmele, Markus Wolschek, Thomas Muster

PLoS One· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1.
Raveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, Sonia Jangra, Thomas Kehrer, Thomas Muster

Sci Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic Protection Against Respiratory Viruses Conferred by a Prototype Live Attenuated Influenza Virus Vaccine.
Raveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, Sonia Jangra, Thomas Kehrer, Thomas Muster

Res Sq· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
Raveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, Sonia Jangra, Thomas Kehrer, Thomas Muster

bioRxiv· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.
Christina Nicolodi, Franz Groiss, Oleg Kiselev, Markus Wolschek, Joachim Seipelt, Thomas Muster

Vaccine· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.
Christoph Jindra, Bettina Huber, Saeed Shafti-Keramat, Markus Wolschek, Boris Ferko, Thomas Muster

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.
Christoph Jindra, Bettina Huber, Saeed Shafti-Keramat, Markus Wolschek, Boris Ferko, Thomas Muster

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice.
Christian Kittel, Nina Wressnigg, Anna Polina Shurygina, Markus Wolschek, Marina Stukova, Thomas Muster

Arch Virol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purification of Vero cell derived live replication deficient influenza A and B virus by ion exchange monolith chromatography.
Marko Banjac, Elisabeth Roethl, Franz Gelhart, Petra Kramberger, Barbara Lah Jarc, Thomas Muster

Vaccine· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines.
Sabine Nakowitsch, Andrea M Waltenberger, Nina Wressnigg, Nicole Ferstl, Andrea Triendl, Thomas Muster

Biotechnol J· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1.
Christina Mössler, Franz Groiss, Michael Wolzt, Markus Wolschek, Joachim Seipelt, Thomas Muster

Vaccine· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in mice.
Hae-Jung Park, Boris Ferko, Young-Ho Byun, Joo-Hye Song, Gye-Yeong Han, Thomas Muster

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame.
Marijke van Rikxoort, Martin Michaelis, Markus Wolschek, Thomas Muster, Andrej Egorov

PLoS One· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture.
Elisabeth Roethl, Manuela Gassner, Brigitte M Krenn, Ekaterina A Romanovskaya-Romanko, Helena Seper, Thomas Muster

J Virol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of human endogenous retrovirus K is stimulated by ultraviolet radiation in melanoma.
Oliver Schanab, Johannes Humer, Andreas Gleiss, Mario Mikula, Sanda Sturlan, Thomas Muster

Pigment Cell Melanoma Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1.
Sabine Nakowitsch, Markus Wolschek, Alexander Morokutti, Tanja Ruthsatz, Brigitte M Krenn, Thomas Muster

Vaccine· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1.
Brigitte M Krenn, Andrej Egorov, Ekaterina Romanovskaya-Romanko, Markus Wolschek, Sabine Nakowitsch, Thomas Muster

PLoS One· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency.
Markus Wolschek, Elisabeth Samm, Helena Seper, Sanda Sturlan, Irina Kuznetsova, Thomas Muster

J Virol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-clinical safety evaluation of pyrrolidine dithiocarbamate.
Monika Chabicovsky, Eva Prieschl-Grassauer, Joachim Seipelt, Thomas Muster, Oliver H J Szolar

Basic Clin Pharmacol Toxicol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells.
Henry Ogbomo, Martin Michaelis, Janina Geiler, Marijke van Rikxoort, Thomas Muster

Med Microbiol Immunol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.
Volker Wacheck, Andrej Egorov, Franz Groiss, Andrea Pfeiffer, Thorsten Fuereder, Thomas Muster

J Infect Dis· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine.
Julia Romanova, Brigitte M Krenn, Markus Wolschek, Boris Ferko, Ekaterina Romanovskaja-Romanko, Thomas Muster

PLoS One· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.
Nina Wressnigg, Daniel Voss, Thorsten Wolff, Julia Romanova, Tanja Ruthsatz, Thomas Muster

Vaccine· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis